Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Toxins (Basel)
2015 Jun 30;77:2534-50. doi: 10.3390/toxins7072534.
Show Gene links
Show Anatomy links
Revealing the Function and the Structural Model of Ts4: Insights into the "Non-Toxic" Toxin from Tityus serrulatus Venom.
Pucca MB
,
Cerni FA
,
Peigneur S
,
Bordon KC
,
Tytgat J
,
Arantes EC
.
???displayArticle.abstract???
The toxin, previously described as a "non-toxic" toxin, was isolated from the scorpion venom of Tityus serrulatus (Ts), responsible for the most severe and the highest number of accidents in Brazil. In this study, the subtype specificity and selectivity of Ts4 was investigated using six mammalian Nav channels (Nav1.2→Nav1.6 and Nav1.8) and two insect Nav channels (DmNav1 and BgNav). The electrophysiological assays showed that Ts4 specifically inhibited the fast inactivation of Nav1.6 channels, the most abundant sodium channel expressed in the adult central nervous system, and can no longer be classified as a "non-toxic peptide". Based on the results, we could classify the Ts4 as a classical α-toxin. The Ts4 3D-structural model was built based on the solved X-ray Ts1 3D-structure, the major toxin from Ts venom with which it shares high sequence identity (65.57%). The Ts4 model revealed a flattened triangular shape constituted by three-stranded antiparallel β-sheet and one α-helix stabilized by four disulfide bonds. The absence of a Lys in the first amino acid residue of the N-terminal of Ts4 is probably the main responsible for its low toxicity. Other key amino acid residues important to the toxicity of α- and β-toxins are discussed here.
Figure 1. Reversed-phase FPLC of fraction VIIIB resulting from the Ts venom fractionation procedure. The fraction VIIIB was submitted to a reversed-phase chromatography on a C18 column (4.6 mm × 250 mm, 5 μm particles) equilibrated with 0.1% (v/v) of trifluoroacetic acid (TFA). Adsorbed proteins were eluted using a concentration gradient from 0% to 100% of solution B (80% acetonitrile in 0.1% TFA), represented by the dotted line. Flow: 0.8 mL/min. Absorbance was monitored at 214 nm, at 25 °C.
Figure 2. Electrophysiological screening of the effect of Ts4 on 8 different cloned voltage-gated sodium channels. Left panels: representative whole-cell current traces. Right panels: effects of Ts4 on the voltage dependence of steady-state activation and inactivation. Control conditions (open symbols) and after the addition of 500 nM Ts4 (closed symbols). Activation is shown by circles and inactivation by triangles.
Figure 3. Ts4 concentration-response curve on Nav1.6. The concentration-response curve was performed using the ∆INaP. The calculated EC50 value is shown above the curve. Data are presented as the mean ± SEM (n ≥ 3). The data were fitted with the Hill 1 equation.
Figure 4. Cartoon representation of Ts1 structure and Ts4 3D-structural model. The cartoons represent the flattened triangular shape structure of the α-helix/β-sheet motif (CSαβ) of Ts1 (blue) and Ts4 (green). The Ts4 different amino acid residues compared to Ts1 are highlighted in orange. (A,B) Face A (front view): Cysteine residues are shown as red stick. (C,D) Face A (front view): Conserved aromatic cluster (yellow). (E,F) Face B (back view): Important structural positive residues (grey). (G,H) Face C (side view): Residues implicated in voltage-gated sodium channel (Nav) activity. N-terminal amino acid residue (green). Residue implicated in β-toxin activity (magenta). Residue implicated in α-toxin activity (cyan). (I) Sequence alignment of Ts4 and Ts1. The alignment of the Ts4 and Ts1 were created by Clustal Omega version 2.1. (*) identical residues; (:) highly conserved residues. Cysteine residues are highlighted in red. The residues are following (A–H) coloring patterns.
Figure 5. Multiple sequence alignment of sodium channel Ts toxins (Ts1-Ts5). The alignment of the Ts1, Ts2, Ts3, Ts4 and Ts5 and identity (%) were created by Clustal Omega version 2.1. (*) identical residues; (:) highly conserved residues. Cysteine residues are highlighted in black. The Lys1 is in red and the Gly1 is in blue.
Alvarenga,
Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes.
2002, Pubmed
Alvarenga,
Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes.
2002,
Pubmed
Arantes,
A simplified procedure for the fractionation of Tityus serrulatus venom: isolation and partial characterization of TsTX-IV, a new neurotoxin.
1989,
Pubmed
Aroui,
Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231.
2009,
Pubmed
Barbalat,
Nucleic acid recognition by the innate immune system.
2011,
Pubmed
Becerril,
Toxins and genes isolated from scorpions of the genus Tityus.
1997,
Pubmed
Bonilha,
Epilepsy due to a destructive brain lesion caused by a scorpion sting.
2004,
Pubmed
Bosmans,
Voltage-gated sodium channel modulation by scorpion alpha-toxins.
2007,
Pubmed
Bosmans,
Deconstructing voltage sensor function and pharmacology in sodium channels.
2008,
Pubmed
,
Xenbase
Carmo,
Molecular and functional characterization of metalloserrulases, new metalloproteases from the Tityus serrulatus venom gland.
2014,
Pubmed
Carrithers,
Expression of the voltage-gated sodium channel NaV1.5 in the macrophage late endosome regulates endosomal acidification.
2007,
Pubmed
Cerni,
Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure.
2014,
Pubmed
,
Xenbase
Chavez-Olortegui,
Molecular basis for the cross-reactivity of antibodies elicited by a natural anatoxin with alpha- and beta-toxins from the venom of Tityus serrulatus scorpion.
2002,
Pubmed
Chaïr-Yousfi,
Androctonus australis hector venom contributes to the interaction between neuropeptides and mast cells in pulmonary hyperresponsiveness.
2015,
Pubmed
Chippaux,
Epidemiology of scorpionism: a global appraisal.
2008,
Pubmed
Chávez-Olórtegui,
Neutralizing capacity of antibodies elicited by a non-toxic protein purified from the venom of the scorpion Tityus serrulatus.
1997,
Pubmed
Coelho,
Functional and structural study comparing the C-terminal amidated β-neurotoxin Ts1 with its isoform Ts1-G isolated from Tityus serrulatus venom.
2014,
Pubmed
Cologna,
Tityus serrulatus scorpion venom and toxins: an overview.
2009,
Pubmed
Cologna,
Purification and characterization of Ts15, the first member of a new α-KTX subfamily from the venom of the Brazilian scorpion Tityus serrulatus.
2011,
Pubmed
Cologna,
Investigation of the relationship between the structure and function of Ts2, a neurotoxin from Tityus serrulatus venom.
2012,
Pubmed
,
Xenbase
DINIZ,
Effects of a toxin present in a purified extract of telsons from the scorpion Tityus serrulatus on smooth muscle preparations and in mice.
1959,
Pubmed
Dalton,
Chlorotoxin-sensitive Ca2+-activated Cl- channel in type R2 reactive astrocytes from adult rat brain.
2003,
Pubmed
Darbon,
Alpha-scorpion neurotoxin derivatives suitable as potential markers of sodium channels. Preparation and characterization.
1983,
Pubmed
DeBin,
Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion.
1993,
Pubmed
Edman,
A protein sequenator.
1967,
Pubmed
FISCHER,
[Venoms of the Brazilian scorpions Tityus serrulatus and Tityus bahiensis].
1957,
Pubmed
Ferreira,
Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom.
1993,
Pubmed
Goldin,
Resurgence of sodium channel research.
2001,
Pubmed
Gomez,
Separation of toxic components from the brazillian scorpion Tityus serrulatus venom.
1966,
Pubmed
Guatimosim,
Molecular cloning and genomic analysis of TsNTxp: an immunogenic protein from Tityus serrulatus scorpion venom.
1999,
Pubmed
Hargus,
Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis.
2013,
Pubmed
Indarte,
Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
2008,
Pubmed
Ismail,
The scorpion envenoming syndrome.
1995,
Pubmed
Jarchum,
Regulation of innate and adaptive immunity by the commensal microbiota.
2011,
Pubmed
Kashimoto,
The aromatic ring of phenylalanine 334 is essential for oligomerization of Vibrio vulnificus hemolysin.
2010,
Pubmed
Kharrat,
Structure-activity relationships of scorpion alpha-neurotoxins: contribution of arginine residues.
1990,
Pubmed
Kievit,
Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
2010,
Pubmed
Koren,
Gating mechanism of a cloned potassium channel expressed in frog oocytes and mammalian cells.
1990,
Pubmed
,
Xenbase
Landon,
Refined solution structure of the anti-mammal and anti-insect LqqIII scorpion toxin: comparison with other scorpion toxins.
1997,
Pubmed
Levin,
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.
1980,
Pubmed
Li,
Crystal structure of an acidic neurotoxin from scorpion Buthus martensii Karsch at 1.85 A resolution.
1996,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Lowe,
A portable device for the electrical extraction of scorpion venom.
2011,
Pubmed
MacDonald,
Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets.
2003,
Pubmed
Marangoni,
The complete amino acid sequence of toxin TsTX-VI isolated from the venom of the scorpion Tityus serrulatus.
1990,
Pubmed
Moreira-Ferreira,
In vivo protection against Tityus serrulatus scorpion toxins by immunization of mice with a non-toxic protein.
1998,
Pubmed
Oller-Salvia,
From venoms to BBB shuttles: Synthesis and blood-brain barrier transport assessment of apamin and a nontoxic analog.
2013,
Pubmed
Omidi,
Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.
2012,
Pubmed
Ortiz,
Scorpion venom components as potential candidates for drug development.
2015,
Pubmed
Pajouhesh,
Medicinal chemical properties of successful central nervous system drugs.
2005,
Pubmed
Peigneur,
A gamut of undiscovered electrophysiological effects produced by Tityus serrulatus toxin 1 on NaV-type isoforms.
2015,
Pubmed
,
Xenbase
Pessini,
A hyaluronidase from Tityus serrulatus scorpion venom: isolation, characterization and inhibition by flavonoids.
2001,
Pubmed
Peter,
Modes of onset of epilepsy and differential diagnosis.
2013,
Pubmed
Petricevich,
Macrophage activation, phagocytosis and intracellular calcium oscillations induced by scorpion toxins from Tityus serrulatus.
2008,
Pubmed
Petricevich,
Scorpion venom and the inflammatory response.
2010,
Pubmed
Petricevich,
Effect of Tityus serrulatus venom on cytokine production and the activity of murine macrophages.
2002,
Pubmed
Pinheiro,
Structural analysis of Tityus serrulatus Ts1 neurotoxin at atomic resolution: insights into interactions with Na+ channels.
2003,
Pubmed
Polikarpov,
Crystal structure of neurotoxin Ts1 from Tityus serrulatus provides insights into the specificity and toxicity of scorpion toxins.
1999,
Pubmed
Possani,
Scorpion toxins from Centruroides noxius and Tityus serrulatus. Primary structures and sequence comparison by metric analysis.
1985,
Pubmed
Possani,
Scorpion toxins specific for Na+-channels.
1999,
Pubmed
Pucca,
Electrophysiological characterization of the first Tityus serrulatus alpha-like toxin, Ts5: Evidence of a pro-inflammatory toxin on macrophages.
2015,
Pubmed
Rodríguez de la Vega,
Current views on scorpion toxins specific for K+-channels.
2004,
Pubmed
Rogawski,
The neurobiology of antiepileptic drugs.
2004,
Pubmed
Sampaio,
Isolation of toxin TsTX-VI from Tityus serrulatus scorpion venom. Effects on the release of neurotransmitters from synaptosomes.
1996,
Pubmed
Saucedo,
New tricks of an old pattern: structural versatility of scorpion toxins with common cysteine spacing.
2012,
Pubmed
,
Xenbase
Scheller,
The pro- and anti-inflammatory properties of the cytokine interleukin-6.
2011,
Pubmed
Singh,
Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells.
1989,
Pubmed
Stanley,
Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.
2008,
Pubmed
Tytgat,
A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies.
1999,
Pubmed
Verano-Braga,
Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom.
2008,
Pubmed
Wagner,
Purification and primary structure determination of Tf4, the first bioactive peptide isolated from the venom of the Brazilian scorpion Tityus fasciolatus.
2003,
Pubmed
Weinberger,
Positions under positive selection--key for selectivity and potency of scorpion alpha-toxins.
2010,
Pubmed
Yu,
Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.
2011,
Pubmed
Zoccal,
Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators.
2011,
Pubmed
Zoccal,
TLR2, TLR4 and CD14 recognize venom-associated molecular patterns from Tityus serrulatus to induce macrophage-derived inflammatory mediators.
2014,
Pubmed
Zoccal,
Ts6 and Ts2 from Tityus serrulatus venom induce inflammation by mechanisms dependent on lipid mediators and cytokine production.
2013,
Pubmed
el Ayeb,
Differential effects of defined chemical modifications on antigenic and pharmacological activities of scorpion alpha and beta toxins.
1986,
Pubmed
